3. Could the VALID Act Cause More Harm Than Good?
Lighthouse Lab Services President Jon Harol recently conducted an informal LinkedIn poll to gauge his audience's response on whether the VALID Act and the additional oversight it would require for LDTs would be beneficial for lab testing and patient access overall.
Out of 185 respondents, 56% responded that the act would be an overall negative and would stifle innovation, while 27% said LDTs do need additional oversight and 17% were unsure.
"While the VALID Act is well intended, no research evidence exists to prove FDA approval of LDTs will make them safer for patients," wrote one commentor.